PHAR

11.5405.18%
MK

Michael K. Levitan

VP of Investor Relations & Corporate Communications

Mr. Michael K. Levitan served as Managing Director of The Trout Group LLC. Mr. Levitan was a Principal of Achelous Partners, LLC. He was a Principal of Global Markets Capital Group, LLC. He oversees the expansion of Achelous Partners’ mergers, acquisitions and advisory efforts in the U.S. and supports Achelous Partners’ efforts with biotechnology, pharmaceuticals and life sciences clients globally. He has over eleven years of healthcare investment banking and corporate development experience, including eight years in M&A and corporate finance principally focused on the biotechnology, pharmaceuticals and life sciences sectors with Wall Street investment banking firms Bear, Stearns & Co. and Lehman Brothers. Mr. Levitan began his investment banking career at Lehman Brothers in 1996. Mr. Levitan joined the Trout Capital LLC in 2007 to expand the capital-raising, M&A and strategic advisory services efforts provided through Trout Capital LLC. Mr. Levitan has 16 years of experience in healthcare investment banking and corporate development, principally focused on the biotechnology, pharmaceuticals, life sciences and life science IT sectors. He has executed a broad range of healthcare transactions totaling over $3 billion in value. At Bear Stearns, Mr. Levitan was responsible for originating and executing a broad range of underwriting and strategic advisory transactions, and distinguished himself as an expert on emerging growth biotechnology and life science technology companies. Mr. Levitan commenced his life sciences career at Eli Lilly, where he worked in business development focusing on medical devices and, following the Guidant spinout, pharmaceuticals licensing and strategic alliances. Mr. Levitan earned an MBA in Finance and Marketing from the University of Chicago Graduate School of Business, and a Bachelor of Engineering degree in electrical and computer engineering from McGill University. He also holds Series 7, 79 and 63 securities licenses.

Positions